Angel News


Back to Homepage

30th March 2021

Caristo Diagnostics receives investment from BGF to bring tech to market

Caristo Diagnostics, the medical imaging company, has completed a multi-million-pound investment round. The round was led by BGF, the UK’s most active growth economy investor, and existing investors including Oxford Sciences Innovation (OSI), Longwall Ventures and the Oxford Technology & Innovation Fund (OTIF).

The funding will be used to roll-out Caristo Diagnostic’s CaRi-Heart®, a ground-breaking AI-based cardiovascular risk prediction technology, which has just received its CE mark accreditation and is available for use by doctors across the UK and Europe.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage